Cargando…

Management of multiple sclerosis in adolescents – current treatment options and related adherence issues

Multiple sclerosis (MS) is a progressive inflammatory demyelinating disorder of the central nervous system that is increasingly recognized in children and adolescents. This realization comes with additional concerns about existing therapeutic options and the impact of the disease on health-related o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mah, Jean K, Thannhauser, Jennifer E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916015/ https://www.ncbi.nlm.nih.gov/pubmed/24600259

Ejemplares similares

Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options
por: Jancic, Jasna, et al.
Publicado: (2016)

Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options
por: Jagirdar, Rajesh M., et al.
Publicado: (2019)

Current treatment options in the management of chronic prostatitis
por: Duclos, Alain Jean, et al.
Publicado: (2007)

Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options – Review Article
por: Zimek, Dalibor, et al.
Publicado: (2023)

Mycoplasma genitalium infections: current treatment options and resistance issues
por: Sethi, Sunil, et al.
Publicado: (2017)

Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options
por: Wang, Shelly, et al.
Publicado: (2014)

Current treatment options for the management of esophageal cancer
por: Mawhinney, Mark R, et al.
Publicado: (2012)

Current and emerging treatment options in the management of lupus
por: Jordan, Natasha, et al.
Publicado: (2016)

Measuring Treatment Response in Progressive Multiple Sclerosis—Considerations for Adapting to an Era of Multiple Treatment Options
por: Krajnc, Nik, et al.
Publicado: (2021)

Luteolin as a therapeutic option for multiple sclerosis
por: Theoharides, Theoharis C
Publicado: (2009)

Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options
por: Andravizou, Athina, et al.
Publicado: (2019)

Treatment of systemic sclerosis associated fibrotic manifestations: Current options and future directions
por: Daoussis, Dimitrios, et al.
Publicado: (2019)

Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies
por: Yeh, E Ann
Publicado: (2010)

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence
por: Patti, Francesco
Publicado: (2010)

Adherence to glatiramer acetate treatment for multiple sclerosis: the Brazilian experience
por: de Oliveira, Tatiana de Melo Gomes, et al.
Publicado: (2008)

Treatment adherence in multiple sclerosis: a survey of Belgian neurologists
por: Decoo, Danny, et al.
Publicado: (2015)

Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain
por: Morillo Verdugo, Ramón, et al.
Publicado: (2019)

Current and emerging treatment options in the management of Friedreich ataxia
por: Mancuso, Michelangelo, et al.
Publicado: (2010)

Management of patients with resistant hypertension: current treatment options
por: Kumar, Nilay, et al.
Publicado: (2013)

Current treatment options for management of anal intraepithelial neoplasia
por: Weis, Stephen E
Publicado: (2013)

Olfactory neuroblastoma: diagnosis, management, and current treatment options
por: Tosoni, Alicia, et al.
Publicado: (2023)

Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab
por: Patti, Francesco, et al.
Publicado: (2009)

Editorial of Special Issue “Multiple Sclerosis: Diagnosis and Treatment II”
por: Rivera, Victor M.
Publicado: (2021)

Walking impairment in patients with multiple sclerosis: exercise training as a treatment option
por: Motl, Robert W, et al.
Publicado: (2010)

Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options
por: Di Stefano, Giulia, et al.
Publicado: (2019)

Cognitive Issues in Pediatric Multiple Sclerosis
por: Portaccio, Emilio, et al.
Publicado: (2021)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism
por: Kneeland, Patrick P, et al.
Publicado: (2010)

Cancer-Related Fatigue: Causes and Current Treatment Options
por: Thong, Melissa S.Y., et al.
Publicado: (2020)

Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
por: Bayas, Antonios, et al.
Publicado: (2015)

Current and Future Biomarkers in Multiple Sclerosis
por: Yang, Jennifer, et al.
Publicado: (2022)

Adherence to Therapy in Patients with Multiple Sclerosis—Review
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2022)

Adherence to Disease-Modifying Therapies for Multiple Sclerosis
por: Higuera, Lucas, et al.
Publicado: (2016)

Managing Behçet’s disease: An update on current and emerging treatment options
por: van Daele, P LA, et al.
Publicado: (2009)

Managing pediatric hepatitis C: current and emerging treatment options
por: Karnsakul, Wikrom, et al.
Publicado: (2009)

Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options
por: Eid, Michal, et al.
Publicado: (2023)

Optimal management of multiple sclerosis during pregnancy: current perspectives
por: Borisow, Nadja, et al.
Publicado: (2014)

Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist
por: Baskaran, Archit B, et al.
Publicado: (2023)

Multiple Sclerosis in Parsis: A Historical Issue
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

Current Treatment Options in CLL
por: Bewarder, Moritz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74sg28qrg38ek2brit50lf06bp